Notice2026-01700
National Cancer Institute; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 28, 2026
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 18 (Wednesday, January 28, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 18 (Wednesday, January 28, 2026)]
[Notices]
[Page 3729]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-01700]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Cancer
Advisory Board.
The meeting will be held in-person and is open to the public as
indicated below. Individuals who plan to view the virtual meeting and
need special assistance or other reasonable accommodations to view the
meeting should notify the Contact Person listed below in advance of the
meeting. The meeting can be accessed from the NIH Videocast at the
following link: <a href="http://videocast.nih.gov/">http://videocast.nih.gov/</a>.
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6),
Title 5 U.S.C., as amended. The grant applications and the discussions
could disclose confidential trade secrets or commercial property such
as patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board.
Date: June 29, 2026.
Open: 6:00 p.m. to 9:00 p.m.
Agenda: National Cancer Advisory Board Subcommittee Meetings.
Place: Gaithersburg Marriott, Washingtonian Center, 9751
Washington Blvd., Gaithersburg, MD 20878 (In Person and Virtual
Meeting).
Date: June 30, 2026.
Open: 9:00 a.m. to 4:00 p.m.
Agenda: Director's and Program reports and presentations;
business of the Board.
Closed: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute--Shady Grove, 9609 Medical
Center Drive, Room TE406 and 408, Rockville, MD 20850 (In Person and
Virtual Meeting).
Contact Person: Shamala K. Srinivas, Ph.D., Associate Director
Division of Extramural Activities, National Cancer Institute--Shady
Grove, National Institutes of Health, 9609 Medical Center Drive, 7th
Floor, Room 7W530, Bethesda, MD 20892, 240-276-6340,
<a href="/cdn-cgi/l/email-protection#483b202925292429082529212466262120662f273e"><span class="__cf_email__" data-cfemail="d6a5beb7bbb7bab796bbb7bfbaf8b8bfbef8b1b9a0">[email protected]</span></a>.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NCI-Shady Grove campus. All
visitors will be asked to show one form of identification (for
example, a government-issued photo ID, driver's license, or
passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home
page: NCAB: <a href="http://deainfo.nci.nih.gov/advisory/ncab/ncab.htm">http://deainfo.nci.nih.gov/advisory/ncab/ncab.htm</a>, where
an agenda and any additional information for the meeting will be
posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: January 26, 2026.
David Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2026-01700 Filed 1-27-26; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 28, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.